BNP PARIBAS FINANCIAL MARKETS - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$114,938,000
-89.9%
19,061
-94.0%
0.00%
-100.0%
Q3 2019$1,143,634,000
+2262.7%
317,676
+1658.9%
0.00%
Q2 2019$48,403,000
-48.0%
18,061
-42.6%
0.00%
Q1 2019$93,074,000
+1825.4%
31,444
+934.3%
0.00%
Q4 2018$4,834,000
-83.0%
3,040
-60.6%
0.00%
Q3 2018$28,417,000
+40.9%
7,722
+8.3%
0.00%
Q2 2018$20,169,000
-82.3%
7,127
-76.8%
0.00%
Q1 2018$113,930,000
+53.2%
30,709
+18.9%
0.00%
Q4 2017$74,379,000
+32.3%
25,826
+106.3%
0.00%
Q3 2017$56,219,000
-25.5%
12,521
-23.8%
0.00%
Q2 2017$75,464,000
+773.5%
16,441
+701.2%
0.00%
Q1 2017$8,639,000
-74.3%
2,052
-74.8%
0.00%
Q4 2016$33,635,000
-57.2%
8,144
-16.0%
0.00%
Q3 2016$78,505,000
+121.0%
9,692
+112.8%
0.00%
Q2 2016$35,529,000
-87.0%
4,555
-82.0%
0.00%
-100.0%
Q4 2015$273,246,000
-10.8%
25,324
-42.8%
0.00%0.0%
Q3 2015$306,161,000
+74.7%
44,307
+124.0%
0.00%
Q2 2015$175,251,000
+40.0%
19,780
+55.8%
0.00%
Q1 2015$125,143,000
+104.3%
12,692
+153.8%
0.00%
Q4 2014$61,250,000
-66.3%
5,000
-72.5%
0.00%
Q3 2014$181,676,000
+17.5%
18,204
-10.9%
0.00%
Q2 2014$154,595,000
+3618.9%
20,422
+1531.2%
0.00%
Q4 2013$4,157,000
-94.8%
1,252
-95.2%
0.00%
Q3 2013$79,378,000
-72.6%
26,284
-25.9%
0.00%
Q2 2013$289,965,00035,4480.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders